BioAdvance

BioAdvance is a venture capital firm that invests in early-stage life sciences companies in the Mid-Atlantic region. Their primary focus is on technologies that have the potential to improve human health, with a particular emphasis on therapeutic agents, medical devices, diagnostics, and healthcare IT. BioAdvance provides seed-stage capital of typically $500,000 to $1,500,000 in two or more tranches, based on value-creating or de-risking milestones. The firm has a deep commitment to the Mid-Atlantic region, investing exclusively in companies located from New York City to Washington D.C., along the I-95 corridor.

BioAdvance has a strong track record of success, having invested in over 100 companies and achieving 23 exits across various sectors. They have a team of experienced professionals with deep industry knowledge who work closely with their portfolio companies to help them achieve their goals. The firm has a strong network of advisors and investors, including a team of Entrepreneur-in-Residence, who are actively involved in supporting the growth of their portfolio companies.

BioAdvance is a venture capital firm that provides early-stage funding to life sciences companies located in the Mid-Atlantic region. They are dedicated to supporting the development of technologies with the potential to improve human health, specifically focusing on therapeutic agents, platform technologies, research tools, medical devices, diagnostics, and healthcare IT. BioAdvance works closely with entrepreneurs to build strong companies and maximize the value of scarce capital, with the goal of ultimately increasing their ability to attract additional funding, secure grant revenue, or partner with larger companies.

BioAdvance promotes a collaborative and entrepreneurial culture, emphasizing teamwork and a shared commitment to improving human health. The company values deep industry experience and invests in individuals with diverse backgrounds, including business executives, scientists, physicians, and entrepreneurs. They foster a culture of innovation and capital efficiency, supporting companies through various stages of growth and working closely with them to achieve success.